BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25774587)

  • 1. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
    Haupt WF; Rosenow F; van der Ven C; Birkmann C
    Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Pham HP; Schwartz J
    Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic apheresis in myasthenia gravis.
    Batocchi AP; Evoli A; Di Schino C; Tonali P
    Ther Apher; 2000 Aug; 4(4):275-9. PubMed ID: 10975473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review of therapeutic plasma exchange in neurological disorders.
    Chhibber V; Weinstein R
    Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption in neurological disorders.
    Oji S; Nomura K
    Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroimmunological diseases: update].
    Kusunoki S
    Nihon Rinsho; 2013 May; 71(5):771-7. PubMed ID: 23777080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
    Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
    Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis in neurological diseases. Experience in 140 procedures in 47 patients].
    Nogales-Gaete J; Valenzuela D; Liendo F; Vidal P; Gil G; Sáez D
    Rev Med Chil; 2004 Mar; 132(3):295-8. PubMed ID: 15376565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic apheresis in neurology critical care.
    Natarajan N; Weinstein R
    J Intensive Care Med; 2005; 20(4):212-25. PubMed ID: 16061904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
    Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
    Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
    Heininger K
    Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
    Somnier FE; Langvad E
    J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.